Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL
Description: Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in the United States, with approximately 90,000 affected individuals and 4,500 attributable deaths per year. Monoclonal B lymphocytosis is an identified precursor state for CLL, and is approximately 100 times more prevalent than CLL. The experiments described herein will clarify the biology of pre-emergent CLL, discover the determinants of progression from MBL to CLL, and identify novel targets for therapeutic intervention in CLL.
Funder: National Cancer Institute
Funding type: career_development
Funder scheme: K08
Start date: 2011-08-01
End date: 2016-07-31
Investigator: MARK C LANASA
Institution: DUKE UNIVERSITY
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Funded outputs count: 18
Funder award ID: K08CA134919
OpenAlex ID: G6134872255
